Creating new catalysts to neutralize toxic substances in the body
Development of Transfer Hydrogenation Small-Molecule Intracellular Metal Catalysts (SIMCats) and their Application Toward Toxic Aldehyde Remediation
This study is looking at new tiny helpers that can safely turn harmful substances in your body into safer ones, which could lead to better treatments for conditions caused by stress and toxins.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10832463 on NIH RePORTER |
What this research studies
This research focuses on developing small-molecule intracellular metal catalysts (SIMCats) that can help detoxify harmful aldehydes in the body. By mimicking natural enzymes, these catalysts aim to convert toxic aldehydes into non-toxic alcohols, thereby supporting the body's natural defense mechanisms against oxidative stress. The project involves identifying key factors for creating effective SIMCats and testing their ability to work safely and efficiently in living systems. Patients may benefit from improved treatments for conditions related to oxidative stress and aldehyde toxicity.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals suffering from conditions associated with oxidative stress, such as cardiovascular diseases or certain cancers.
Not a fit: Patients with conditions unrelated to oxidative stress or aldehyde toxicity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance the body's ability to detoxify harmful substances, potentially improving outcomes for patients with oxidative stress-related conditions.
How similar studies have performed: While the concept of using synthetic catalysts in biological systems is innovative, similar approaches have shown promise in other areas of biochemistry, suggesting potential for success.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Do, Loi Hung — University of Houston
- Study coordinator: Do, Loi Hung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.